Y-mAbs Therapeutics Inc. (YMAB)
Y-mAbs Therapeutics Max Pain By Strike
YMAB trades at $8.53, 13.7% above the near-term max pain of $7.5 expiring Sep 19, 2025 (32 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is falling across expirations ($2.5-$9), signaling increased put positioning or downside protection. Key magnetic zone at 8 where 3 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.
Y-mAbs Therapeutics Max Pain By Expiry
Max pain for YMAB shows a downward trend from 9 to 2.5, indicating bearish sentiment or hedging activity. The 96% spread signals divergent expectations across timeframes. Most levels below 8.53 may cap rallies. Strong magnetic level at 8 (3 expirations). Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.
Max Pain Table
| Expiration Date | Max Pain | Max Pain vs Current Price |
|---|---|---|
| Sep 19, 2025 | 7.5 | -1.03 (-12.08%) |
| Oct 17, 2025 | 2.5 | -6.03 (-70.69%) |
| Nov 21, 2025 | 7.5 | -1.03 (-12.08%) |
| Jan 16, 2026 | 9 | 0.47 (5.51%) |
| Feb 20, 2026 | 7.5 | -1.03 (-12.08%) |